References
- Paul WE. Can the immune response control HIV infec-tion? Cell 1995; 82: 177–82.
- McCune JM. Viral latency in HIV disease. Cell 1995; 82: 183–8.
- Shearer G, Clerici M. Protective immunity against HIV infection: has nature done the experiment for us? Immunol Today 1996; 17: 21–24.
- Baltimore D. Lessons from people with nonprogressive HIV infection. N Engl J Med 1995; 332: 259–60.
- Toth FD, Szabo B, Ujhelyi E, et al. Neutralizing and complement-dependent enhancing antibodies in different stages of HIV infection. AIDS 1991; 5: 263–8.
- Riviere Y. Virus-specific cytotoxic T lymphocyte responses in patients infected with the human immunodefi-ciency virus, HIV-1. Cell Mol Biol 1994; 40: 45–8.
- Walker BD, Chakrabarti S, Moss B, et al. HIV-specific cytotoxic T lymphocytes in seropositive individuals. Nature 1987; 328: 345–8.
- Langlade-Demoyen P, Ngo-Giang-Huong N, Ferchal F, Oksenhendler E. HIV nef-specific cytotoxic T lymphocytes in non-infected heterosexual contact of HIV-infected patients. J Clin Invest 1994; 93: 1293–7.
- Harrer E, Harrer T, Buchbinder S, et al. HIV-1-specific cytotoxic T lymphocyte response in healthy, long-term non-progressing seropositive persons. AIDS Res Hum Retroviruses 1994; 10: S77–8.
- Walker CM, Moody DJ, Stites DP, Levy JA. CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication. Science 1986; 234: 1563–6.
- Mackewicz CE, Ortega HW, Levy JA. CD8+ cell anti-HIV activity correlates with the clinical state of the infected individual. J Clin Invest 1991; 87: 1462–6.
- Cocchi F, DeVico AL, Garzino-Demo A, Arya SK, Gallo RC, Lusso P. Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV- suppressive factors pro-duced by CD8+ T cells . Science 1995; 270: 1811–5.
- Feng Y, Broder CC, Kennedy PE, Berger EA. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmem-brane, G protein-coupled receptor. Science 1996; 272: 872–7.
- Lusso P, Gallo R. Chemokines and HIV infection. Curr Op Infect Dis 1997; 10: 12–17.
- Furci L, Scarlatti G, Burastero S, et al. Antigen-driven C-C chemokine-mediated HIV-1 suppression by CD4(+) T cells from exposed uninfected individuals expressing the wild-type CCR- 5 allele. J Exp Med 1997; 186: 455–60.
- Saha K, Bentsman G, Chess L, Volsky DJ. Endogenous production of beta-chemokines by CD4+, but not CD8+, T-cell clones correlates with the clinical state of human immunodeficiency virus type 1 (HIV-1)-infected individuals and may be responsible for blocking infection with non-syncytium-inducing HIV-1 in vitro. J Virol 1998; 72: 876–81.
- Liu R, Paxton WA, Choe S, et al. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply- exposed individuals to HIV-1 infection. Cell 1996; 86: 367–77.
- Samson M, Libert F, Doranz BJ, et al. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 1996; 382: 722–5.
- Bleul CC, Farzan M, Choe H, et al. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature 1996; 382: 829–33.
- Oberlin E, Amara A, Bachelerie F, et al. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature 1996; 382: 833–5.
- Polo S, Furci L, Tresoldi E, et al. Expression of macrophage derived chemokine (MDC), but not of stromal cell-derived factor-1 (SDF-1) by ex-vivo activated CD8+ T cells from HIV-1 seropositive patients. Submitted for publication 1998.
- Lacey SF, McDanal CB, Horuk R, Greenberg ML. The CXC chemokine stromal cell-derived factor 1 is not responsi-ble for CD8+ T cell suppression of syncytia-inducing strains of HIV-1. Proc Natl Acad Sci USA 1997; 94: 9842–7.
- Winkler C, Modi W, Smith MW, et al. Genetic restric-tion of AIDS pathogenesis by an SDF-1 chemokine gene vari-ant. Science 1998; 279: 389–93.
- Pal R, Garzino-Demo A, Markham PD, et al. Inhibition of HIV-1 infection by the beta-chemokine MDC. Science 1997; 278: 695–8.
- Chen CH, Weinhold KJ, Bartlett JA, Bolognesi DP, Greenberg ML. CD8+ T lymphocyte-mediated inhibition of HIV-1 long terminal repeat transcription: a novel antiviral mechanism. AIDS Res Human Retroviruses 1993; 9: 1079-86.